Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin

Kidney International

Volumn 54, Issue 5, 1998, Pages 1637-1651

  Sengoelge, Gürkan ^b   Födinger, Manuela ^b   Skoupy, Sonja ^b   Ferrara, Ilse ^b   Zangerle, Christa ^b   Rogy, Michael ^b   Hörl, Walter H ^b   Sunder Plassmann, Gere ^a   Menzel, Johannes ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Advanced glycation end products; Diabetes; E selectin; Endothelial cells; ICAM 1; Inflammatory mediators; PECAM; Polymorphonuclear leukocytes; Uremia; VCAM 1

Indexed keywords

CD31 ANTIGEN; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; GLYCATION; HUMAN; HUMAN CELL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031728245     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00157.x     Document Type: Article

References (44)

1. RUDERMAN NB, HAUDENSCHILD C: Diabetes as an atherogenic factor. Progr Cardiovasc Dis 26:373-412, 1984
2. MANSKE CL, WILSON RF, WANG Y, THOMAS W: Prevalence of, and risk factors for, angiographically determined coronary artery disease in type 1 diabetic patients with nephropathy. Arch Intern Med 152: 2450-2455, 1992
3. WHFELER DC: Cardiovascular disease in patients with chronic renal failure. Lancet 348:1673-1674, 1996
4. BELCH JJ: The relationship between white blood cells and arterial disease. Curr Opin Lipidol 5:440-446, 1994
5. CYBULSKY MI, GIMBRONE MA JR: Endothelial expression of a mononuclear leukoeyte adhesion molecule during atherogenesis. Science 251:788-791, 1991
6. LI H, CYBULSKY MI, GIMBRONE MA, LIBBY P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb 13:197-204, 1993
7. VAN DER WAL AC, DAS PK, TIGGES AJ, BECKER AE: Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141:1427-1433, 1992
8. O'BRIEN KD, ALLEN MD, MCDONALD TO, CHATT A, HARLAN JM, FISHBEIN D, MCCARTY J, FERGUSON M, HUDKINS K, BENJAMIN CD, LOBR R, ALPERS CE: Vaseular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945951, 1993
9. BEVILACOA MP, NELSON RM, MANNORI G, CECCONI O: Endothelialleukocyte adhesion molecules in human disease. Annu Rev Med 45:361-378, 1994
10. POSTONN RN, HASKARD DO, COUCHFR JR, GALL NP, JOHNSON-TIDEY RR: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140:665-678, 1992
11. RICHARDSON M, HADCOCK SJ, DERESKE M, CYBULSKY MI: Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 14:760-769, 1994
12. HAKKERT BC, KUIJPERS TW, LEEUWENBERG JFM, VAN MOURIK JA, ROOS D: Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: The contribution of CD18, ELAM-1 and VLA-4. Blood 78:2721-2726, 1991
13. POSTON RN, JOHNSON-TIDEY RR: Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: Implications for atherogenesis. Am J Pathol 144:73-80, 1996
14. MAKITA Z, RADOFF S, RAYFIEID EJ, YANG Z, SKOLNIK E, DELANEY V, FRIEDMAN EA, CERAMI A, VLASSAKA H: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
15. NAKAMURA Y, HORII Y, NISHINO T, SHIIKI H, SAKAGUCIU Y, KAGOSHIMA T, DOHI K, MAKITA Z, VLASSAKA H, BUCALA R: Immunchistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol 143:1649-1656, 1993
16. VLASSAKA H, BUCALA R, STRIKER L: Biology of disease: Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151, 1994
17. ESPOSITO C, GMRLACH H, BRETT J, STERN D, VLASSARA H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407, 1989
18. BUCALA R, TRACEY KJ, CERAMI A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
19. HAAG-WEBER M, HÖRL WH: Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uremia? Nephrol Dial Transplant 11(Suppl 2):S98-S100, 1996
20. HAAG-WEBER M, HÖRL WH: Uremia and infection: Mechanisms of impaired cellular host defense. Nephron 63:125-131, 1993
21. JAFFE EA, NACHMAN RL, BECKER CG, MINICK CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756, 1973
22. CHOMCZYNSKI P, SACCMI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-169, 1987
23. MAURER J, JANSSEN JW, THIEL E, VAN DENDEREN J, LUDWIG WD, AYDEMIR U, HEINZE B, FONATSCH C, HARBOTT J, REITER A, RIEHM H, HOELZER D, BARTRAM CR: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 337:1055-1058, 1991
24. RUSSELL ME, ADAMS DH, WYNER LR, YAMASHITA Y, HALNON NJ, KARNOVSKY MJ: Early and persistent induction of monocyte chemoattractant protein in rat cardiac allografts. Proc. Natl Acad Sci USA 90:6086-6090, 1993
25. KIRSCHBAUM NE, GUMINA RJ, NEWMAN PJ: Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex eytoplasmic domain. Blood 84:4028-4037, 1994
26. SAITO I, TERAUCHI K, SHIMUTA M, NISHIIMURA S, YOSHINO K, TAKEUCHI T, TSUBOTA K, MIYASAKA N: Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal 7:180-187, 1993
27. GEISSLER K, ÖHER L, FÖDINGER M, VIRGOLINI I, LEIMER M, KABRNA E, KOLLARS M, SKOUPY S, BOHLE B, ROGY M, LECHNER K: Interleukin-10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J Exp Med 184:1377-1384, 1996
28. METCALF JA, GALLIN JI, NAUSEEF WM, ROOT RK: Laboratory Manual of Neutrophil Function. New York, Raven Press, 1986, pp 3-17
29. SUNDER-PLASSMANN G, HOFBAUER R, SENGOELGE G, HÖRL WH: Quantification of leukocyte migration: Improvement of a method. Immunol Invest 25:49-63, 1996
30. SCHMIDT AM, ZHANG JH, CRANDALL J, CAO R, YAN SD, BRETT J, STERN D: Interaction of advanced glycation endproducts with their endothelial cell receptor leads to enhanced expression of VCAM-1: A mechanism for augmented monocyte vessel wall interactions in diabetes, (abstract) FASEB J 8(Part II):662, 1994
31. VLASSARA H, FUH H, DONNELLY T, CYBULSKY M: Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol Med 1:447-456, 1995
32. SCHMIDT AM, HORI O, CHEN JX, LI JF, CRANDALL J, ZHANG J, CAO R, YAN SD, BRETT J, STERN D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995
33. BOBBINK IWG, DE BOER HC, TEKELENBURG WLH, BANGA JD, DE GROOT PG: Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: Involvement of vitronectin. Diabetes 46:87-93, 1997
34. CARLOS TM, HARLAN JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994
35. MULLER WA, WEIGL SA, DENG X, PHILLIPS DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-460, 1993
36. ROSS R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801-809, 1993
37. KIRSTEIN M, BRETT J, RADOFF S, OGAWA S, STERN D, VLASSARA H: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87:9010-9014, 1990
38. ROT A: Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur J Immunol 23:303-306, 1993
39. MAYROVITZ HN, WIEDMAN MP, TUMA RF: Factors influencing leukocyte adherence in microvessels. Thromb Haemost 38:823-830, 1977
40. WELBOURN R, GOLDMAN G, KOBZIK L, PATERSON I, VALERI CR, SHEPRO D, HECHTMAN HB: Neutrophil adherence receptors (CD18) in ischemia. Dissociation between quantitative cell surface expression and diapedesis mediated by leukotriene B4. J Immunol 145:1906-1911, 1990
41. ZIMMERMANN GA, PRESCOTT SM, MCINTYRE TM: Endothelial interactions with granulocytes: Tethering and signaling molecules. Immunol Today 13:93-100, 1992
42. NICULESCU F, RUS HG, VLAICU R: Activation of the terminal complement pathway in atherosclerosis. Clin Immunol Immunopathol 45:147-155, 1987
43. SCHMIDT AM, HORI O, BRETT J, YAN SD, WAUTIER JL, STERN D: Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528, 1994
44. COLLINS T, READ MA, NEISH AS, WHITLEY MZ, THANOS D, MANIATIS T: Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 9:899-909, 1995